Bausch Health Companies Inc. Novartis AG
Pfizer Inc. Bristol-Myers Squibb Company
Johnson & Johnson
Merck & Co. Inc. Amgen Inc. AbbVie Inc. Eli Lilly and Company
Galderma S.A. GlaxoSmithKline plc
Mylan N.V.
Published | Pages | Publisher | Report code |
---|---|---|---|
Mar 2021 | 187 | MarkNtel Advisors | ASDR-576063 |
Bausch Health Companies Inc. Novartis AG
Pfizer Inc. Bristol-Myers Squibb Company
Johnson & Johnson
Merck & Co. Inc. Amgen Inc. AbbVie Inc. Eli Lilly and Company
Galderma S.A. GlaxoSmithKline plc
Mylan N.V.